328 related articles for article (PubMed ID: 26640374)
1. Nanotechnology-based inhalation treatments for lung cancer: state of the art.
Ahmad J; Akhter S; Rizwanullah M; Amin S; Rahman M; Ahmad MZ; Rizvi MA; Kamal MA; Ahmad FJ
Nanotechnol Sci Appl; 2015; 8():55-66. PubMed ID: 26640374
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Nanocarrier-Mediated Drug Delivery via Inhalational Route for Lung Cancer Therapy: A Systematic and Updated Review.
Ara N; Hafeez A
AAPS PharmSciTech; 2024 Feb; 25(3):47. PubMed ID: 38424367
[TBL] [Abstract][Full Text] [Related]
4. Surface-engineered smart nanocarrier-based inhalation formulations for targeted lung cancer chemotherapy: a review of current practices.
Yu XY; Jin X; Shou ZX
Drug Deliv; 2021 Dec; 28(1):1995-2010. PubMed ID: 34569401
[TBL] [Abstract][Full Text] [Related]
5. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
6. The Nanosystems Involved in Treating Lung Cancer.
Crintea A; Dutu AG; Samasca G; Florian IA; Lupan I; Craciun AM
Life (Basel); 2021 Jul; 11(7):. PubMed ID: 34357054
[TBL] [Abstract][Full Text] [Related]
7. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
[TBL] [Abstract][Full Text] [Related]
8. Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention.
Garbuzenko OB; Mainelis G; Taratula O; Minko T
Cancer Biol Med; 2014 Mar; 11(1):44-55. PubMed ID: 24738038
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Treatment of Lung Cancer: Nanoparticle-based Drug and siRNA Delivery Systems.
Gencer A; Duraloglu C; Ozbay S; Ciftci TT; Yabanoglu-Ciftci S; Arica B
Curr Drug Deliv; 2021; 18(2):103-120. PubMed ID: 32748745
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnology applications in thoracic surgery.
Hofferberth SC; Grinstaff MW; Colson YL
Eur J Cardiothorac Surg; 2016 Jul; 50(1):6-16. PubMed ID: 26843431
[TBL] [Abstract][Full Text] [Related]
11. Respirable nanocarriers as a promising strategy for antitubercular drug delivery.
Mehanna MM; Mohyeldin SM; Elgindy NA
J Control Release; 2014 Aug; 187():183-97. PubMed ID: 24878180
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer: active therapeutic targeting and inhalational nanoproduct design.
Alhajj N; Chee CF; Wong TW; Rahman NA; Abu Kasim NH; Colombo P
Expert Opin Drug Deliv; 2018 Dec; 15(12):1223-1247. PubMed ID: 30422017
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary drug delivery: a role for polymeric nanoparticles?
d'Angelo I; Conte C; Miro A; Quaglia F; Ungaro F
Curr Top Med Chem; 2015; 15(4):386-400. PubMed ID: 25579350
[TBL] [Abstract][Full Text] [Related]
14. Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapy.
Garbuzenko OB; Kuzmov A; Taratula O; Pine SR; Minko T
Theranostics; 2019; 9(26):8362-8376. PubMed ID: 31754402
[TBL] [Abstract][Full Text] [Related]
15. Nano-Therapeutics for the Lung: State-of-the-Art and Future Perspectives.
Iyer R; Hsia CC; Nguyen KT
Curr Pharm Des; 2015; 21(36):5233-44. PubMed ID: 26412358
[TBL] [Abstract][Full Text] [Related]
16. Recent progress of drug nanoformulations targeting to brain.
Khan AR; Yang X; Fu M; Zhai G
J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
[TBL] [Abstract][Full Text] [Related]
17. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle delivery systems, general approaches, and their implementation in multiple myeloma.
de la Puente P; Azab AK
Eur J Haematol; 2017 Jun; 98(6):529-541. PubMed ID: 28208215
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary delivery of anti-inflammatory agents.
Ali ME; McConville JT; Lamprecht A
Expert Opin Drug Deliv; 2015 Jun; 12(6):929-45. PubMed ID: 25534260
[TBL] [Abstract][Full Text] [Related]
20. Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates.
Abdelaziz HM; Gaber M; Abd-Elwakil MM; Mabrouk MT; Elgohary MM; Kamel NM; Kabary DM; Freag MS; Samaha MW; Mortada SM; Elkhodairy KA; Fang JY; Elzoghby AO
J Control Release; 2018 Jan; 269():374-392. PubMed ID: 29180168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
